Long-term exposure of human blood vessels to HIV gp120, morphine, and anandamide increases endothelial adhesion of monocytes: Uncoupling of nitric oxide release

Journal of Cardiovascular Pharmacology

Volumn 31, Issue 6, 1998, Pages 862-868

  Stefano, George B ^a,b   Salzet, Michel ^c   Bilfinger, Thomas V ^a,b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c UNIV LILLE   (France)

Author keywords

Anandamide; Chemokinesis; HIV gp120; Monocytes; Morphine

Indexed keywords

ANANDAMIDE; GLYCOPROTEIN GP 120; MORPHINE; NITRIC OXIDE;

ARTICLE; CARDIOVASCULAR DISEASE; CELL MIGRATION; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE ADHERENCE; PRIORITY JOURNAL; SUBSTANCE ABUSE; VASCULAR ENDOTHELIUM; VIRUS ENVELOPE; VIRUS LOAD;

ARACHIDONIC ACIDS; BLOOD VESSELS; CELL ADHESION; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; HIV ENVELOPE PROTEIN GP120; HUMANS; MONOCYTES; MORPHINE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; POLYUNSATURATED ALKAMIDES;

EID: 0031779955     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199806000-00009     Document Type: Article

References (50)

1. Stefano GB, Smith EM, Cadet P, et al. HIV gp120 alteration of DAMA and IL-1a induced chemotaxic responses in human and invertebrate immunocytes. J Neuroimmunology 1993;43:177-84.
2. Brenneman DE, McCune SK, Mervis RF, et al. gp120 As an etiologic agent for neuroAIDS: neurotoxicity and model systems. Adv Neuroimmunol 1994;4:157-66.
3. Gendelman HE, Genis P, Jett M, et al. An experimental model system for HIV-1-induced brain injury. Adv Neuroimmunol 1994;4:189-94.
4. Tubaro E, Borelli G, Croce C, et al. Effect of morphine on resistance to infection. J Inject Dis 1983;148:656-66.
5. Ruff MR, Wahl SM, Mergenhagen S, et al. Opiate receptor-mediated chemotaxis of human monocytes. Neuropeptides 1985;5:363-6.
6. Peterson PK, Sharp B, Gekker G, et al. Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity. J Immunol 1987;138:3907-12.
7. Peterson PK, Sharp B, Gekker G, et al. Opioid mediated suppression of interferon-γ production by cultured peripheral blood mononuclear cells. J Clin Invest 1987;80:824-31.
8. Bayer BM, Flores CM, Watson RR, eds. Drugs abuse immune function: effects of morphine on lymphocyte function: possible mechanisms of interaction. Boca Raton: CRC Press, 1990:151-74.
9. Liu Y, Blackcourn DJ, Chuang LF, et al. Effects of in vivo and in vitro administration of morphine sulfate upon rhesus macaque polymorphonuclear cell phagocytosis and chemotaxis. J Pharmacol Exp Ther 1992;263:533-9.
10. Molitor TW, Morilla A, Risdahl J, et al. Chronic morphine administration impairs cell-mediated immune responses in swine. J Pharmacol Exp Ther 1992;260:581-6.
11. Perez-Castrillon JP, Perez-Arellano JP, Garcia-Palomo JD, et al. Opioids depress in vitro human monocyte chemotaxis. Immunopharmacology 1992;23:57-61.
12. Lysle DT, Coussons ME, Wans VJ, et al. Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone. J Pharmacol Exp Ther 1993;265:1071-8.
13. Rojavin M, Szabo I, Bussiere JL, et al. Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages. Life Sci 1993;53:997-1006.
14. Stefano GB, Digenis A, Spector S, et al. Opiatelike substances in an invertebrate, a novel opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression. Proc Natl Acad Sci U S A 1993;90:11099-103.
15. Stefano GB, Scharrer B, Smith EM, et al. Opioid and opiate immunoregulatory processes. Crit Rev Immunol 1996;16(2):109-44.
16. Yeager MR, Colacchio TA, Yu CT, et al. Morphine inhibits spontaneous and cytokine-enchanced natural killer cell cytotoxicity in volunteers. Anesthesiology 1995;83:500-8.
17. Makman MH, Bilfinger TV, Stefano GB. Human granulocytes contain an opiate receptor mediating inhibition of cytokine-induced activation and chemotaxis. J Immunol 1995;154:1323-30.
18. Friedman M, Cepero ML, Klein T, et al. Suppressive effect of delta-9-tetrahydrocannabinol in vitro on phagocytosis by murine macrophages. Proc Soc Exp Biol Med 1986;182(2):225-8.
19. Lopez-Cepero M, Friedman M, Klein T, et al. Tetrahydrocannabinol-induced suppression of macrophage spreading and phagocytic activity in vitro. J Leukoc Biol 1986;39(6):679-86.
20. Specter S, Lancz G, Goodfellow D. Suppression of human macrophage function in vitro by delta-9-tetrahydrocannabinol. J Leukoc Biol 1991;50(5):423-6.
21. Devane MA, Hanus L, Breuer A, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992;258:1946-9.
22. Tang JL, Lancz G, Spector S, et al. Marijuana and immunity: tetrahydrocannabinol-mediated inhibition of growth and phagocytic activity of the murine macrophage cell line. P388D1. Int J Immunopharm 1992;14(2):253-62.
23. Zheng ZM, Spector S, Friedman H. Inhibition by delta-9-tetrahydrocannabinol of tumor necrosis factor alpha production by mouse and human macrophages. Int J Immunopharm 1992;14(8):1445-52.
24. Cabral GA, Fischer-Stenger K. Inhibition of macrophage inducible protein expression by delta-9-tetrahydrocannabinol. Life Sci 1994;54(23):1831-44.
25. Burnette-Curley D, Cabral GA. Differential inhibition of RAW264.7 macrophage tumoricidal activity by delta 9-tetrahydrocannabinol. Proc Soc Exp Biol Med 1995;210(1):64-76.
26. McCoy KL, Gainey D, Cabral GA. delta-9-Tetrahydrocannabinol modulates antigen processing by macrophages. J Pharmacol Exp Ther 1995;273(3):1216-23.
27. Stefano GB, Liu Y, Goligorsky MS. Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes. J Biol Chem 1996;271:19238-42.
28. Stefano GB. Role of opioid neuropeptides in immunoregulation. Prog Neurobiol 1989;33:149-59.
29. 3 opiate receptor in endothelial cells: coupling to nitric oxide production and vasodilation. J Biol Chem 1995;270(51):30290-3.
30. Magazine HI, Liu Y, Bilfinger TV, et al. Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide. J Immunol 1996;156:4845-50.
31. Bilfinger TV, Hartman A, Liu Y, et al. Cryopreserved veins used for myocardial revascularization: a 5 year experience and a possible mechanism for their increased failure. Ann Thorac Surg 1997;63:1063-9.
32. Stefano GB, Christensen VB, Tonnesen E, et al. Interleukin 10 stimulation of endogenous nitric oxide release from human saphenous veins diminishes immunocyte adherence. J Cardiovasc Pharmacol 1997;30:90-5.
33. Shrikant P, Benos DJ, Tang LP, et al. HIV glycoprotein 120 enhances intercellular adhesion molecule-1 gene expression in glial cells: involvement of Janus kinase/signal transducer and activator of transcription and protein kinase C signaling pathways. J Immunol 1996;156(3):1307-14.
34. Pinegin BV, Saidov MZ, Scheltsyna TL, et al. Peripheral blood neutrophils from HIV-1 infected individuals are armed with factors that cause inhibition of their migration in response to specific antigens. Immunol Lett 1993;36(1):13-7.
35. Birdsall HH, Trial J, Hallum JA, et al. Phenotypic and functional activation of monocytes in HIV-1 infection: interactions with neural cells. J Leukoc Biol 1994;56(3):310-7.
36. Chao CC, Sharp BM, Pomeroy C, et al. Lethality of morphine in mice infected with Toxoplasma gondii. J Pharmacol Exp Ther 1990;252:605-9.
37. Chao CC, Sharp BM, Pomeroy C, et al. Effects of morphine addiction on the pathogenesis of murine toxoplasmosis. Adv Exp Med Biol 1991;288:223-7.
38. Mintz M. Clinical comparison of adult and pediatric neuroAIDS. Adv Neuroimmunol 1994;4:207-22.
39. Peterson PK, Sharp B, Gekker G, et al. Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS 1990;4P:869-73.
40. Peterson PK, Gekker G, Hu S, et al. Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells. J Neuroimmunol 1994;50:167-75.
41. Schweitzer C, Keller F, Schmitt MP, et al. Morphine stimulates HIV replication in primary cultures of human Kupffer cells. Res Virol 1991;142:189-95.
42. Chuang LF, Killam KF, Jr, Chuang RY. Increased replication of simian immunodeficiency virus in CEM x 174 cells by morphine sulfate. Biochem Biophys Res Commun 1993;195:1165-73.
43. Donahoe RM. Neuroimmunomodulation by opiates: relationship to HIV-1 infection and AIDS. Adv Neuroimmunol 1993;3:31-46.
44. Wiley CA, Schreier R, Nelson J, et al. Cellular localization of human immunodeficiency virus infection within the brains of acquired immunodeficiency syndrome patients. Proc Natl Acad Sci U S A 1986;83:7089-93.
45. Koenig S, Gendelman HE, Orenstein J, et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986;233:819-36.
46. Stoler MH, Eskin TA, Benn S, et al. Human T-cell lymphotropic virus type III infection of the central nervous system: a preliminary in situ analysis. JAMA 1986;256:2360-4.
47. Gabuzda D, Ho DD, de la Monte SM, et al. Immunohistochemical identification of HTLV III antigen in brains of patients with AIDS. Ann Neurol 1986;20:289-95.
48. Moses AV, Nelson JA. HIV infection of human brain capillary endothelial cells: implication for AIDS dementia. Adv Neuroimmunol 1994;4:239-48.
49. Hurwitz AA, Berman JW, Lyman WD. The role of the blood brain barrier in HIV infection of the central nervous system. Adv Neuroimmunol 1994;4:249-56.
50. Stefano GB, Salzet M, Magazine HI, Bilfinger TV. Antagonism of LPS and IFN-γ induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase. J Cardiovasc Pharmacol 1998;31:813-20.